Intersect ENT Inc
XENT
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
$29.39
4.1% upside
Current Fair Value
4.1% upsideUndervalued by 4.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $131.98 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.8 |
| Beta | 1.53 |
| Outstanding Shares | 33,735,000 |
Return
| Return on Equity | 181.29% |
|---|---|
| Return on Assets | -133.81% |
| Return on Invested Capital | -200.74% |
Valuation & Multiples
| P/E Ratio | -5.89 |
|---|---|
| PEG | -10.89 |
| Price to Sales | 9.41 |
| Price to Book Ratio | -9.41 |
| Enterprise Value to Revenue | 1.27 |
| Enterprise Value to EBIT | -0.81 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.19 |
| Debt to Equity | -1.68 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Intersect ENT Inc
CEO: Thomas West